Bacteroides acidifaciens in the gut plays a protective role against CD95-mediated liver injury

References

• Mieli-Vergani G, Vergani D, Czaja A, Manns M, Krawitt E, Vierling J, Lohse A, Montano-Loza A. Autoimmune hepatitis. Nat Rev Dis Primers. 2018;4:18018. doi:10.1038/nrdp.2018.18.
   PubMed Web of Science ®Google Scholar
• Kusters S, Gantner F, Kunstle G, Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology. 1996;111:462–22. doi:10.1053/gast.1996.v111.pm8690213.
   PubMed Web of Science ®Google Scholar
• Gao B, Radaeva S, Park O. Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J Leukoc Biol. 2009;86:513–528. doi:10.1189/JLB.0309135.
   PubMed Web of Science ®Google Scholar
• Tiegs G. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest. 1992;90:196–203. doi:10.1172/JCI115836.
   PubMed Web of Science ®Google Scholar
• McCuskey R, Bethea N, Wong J, McCuskey M, Abril E, Wang X, Ito Y, DeLeve L. Ethanol binging exacerbates sinusoidal endothelial and parenchymal injury elicited by Acetaminophen. J Hepatol. 2005;42:371–377. doi:10.1016/j.jhep.2004.11.033.
   PubMed Web of Science ®Google Scholar
• Lazic M, Eguchi A, Berk M, Povero D, Papouchado B, Mulya A, Johnson C, Feldstein A. Differential regulation of inflammation and apoptosis in Fas-resistant hepatocyte-specific Bid-deficient mice. J Hepatol. 2014;61:107–115. doi:10.1016/j.jhep.2014.03.028.
   PubMed Web of Science ®Google Scholar
• Tagawa YI, And SK, Iwakura Y. Involvement of Fas/Fas ligand system-mediated apoptosis in the development of concanavalin A-induced hepatitis. Eur J Immunol. 1998;28:4105–4113. doi:10.1002/(SICI)1521-4141(199812)28:12<4105::AID-IMMU4105>3.0.CO;2-8.
   PubMed Web of Science ®Google Scholar
• Song E, Lee S, Wang J, Ince N, Ouyang N, Min J, Chen J, Shankar P, Lieberman J. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med. 2003;9:347–351. doi:10.1038/nm828.
   PubMed Web of Science ®Google Scholar
• Minagawa M, Deng Q, Liu Z, Tsukamoto H, Dennert G. Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption. Gastroenterology. 2004;126:1387–1399. doi:10.1053/j.gastro.2004.01.022.
   PubMed Web of Science ®Google Scholar
• Wedemeyer I, Bechmann L, Odenthal M, Jochum C, Marquitan G, Drebber U, Gerken G, Gieseler R, Dienes H, Canbay A. Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C. J Hepatol. 2009;50:140–149. doi:10.1016/j.jhep.2008.08.023.
   PubMed Web of Science ®Google Scholar
• Schulze-Bergkamen H, Untergasser A, Dax A, Vogel H, Büchler P, Klar E, Lehnert T, Friess H, Büchler M, Kirschfink M, et al. Primary human hepatocytes–a valuable tool for investigation of apoptosis and hepatitis B virus infection. J Hepatol. 2003;38:736–744. doi:10.1016/s0168-8278(03)00120-x.
   PubMed Web of Science ®Google Scholar
• Nakamura M, Nagano H, Sakon M, Yamamoto T, Ota H, Wada H, Damdinsuren B, Noda T, Marubashi S, Miyamoto A, et al. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro. J Hepatol. 2007;46:77–88. doi:10.1016/j.jhep.2006.07.032.
   PubMed Web of Science ®Google Scholar
• Gaspar-Elsas M, Queto T, Masid-de-brito D, Vieira B, de Luca B, Cunha F, Xavier-Elsas P. α-Galactosylceramide suppresses murine eosinophil production through interferon-γ-dependent induction of NO synthase and CD95. Br J Pharmacol. 2015;172:3313–3325. doi:10.1111/bph.13126.
   PubMed Web of Science ®Google Scholar
• Celaj S, Gleeson MW, Deng J, O’Toole GA, Hampton TH, Toft MF, Morrison HG, Sogin ML, Putra J, Suriawinata AA, et al. The microbiota regulates susceptibility to Fas-mediated acute hepatic injury. Lab Invest. 2014;94:938–949. doi:10.1038/labinvest.2014.93.
   PubMed Web of Science ®Google Scholar
• Vasconcelos J, Bruña-Romero O, Araújo A, Dominguez M, Ersching J, de Alencar B, Machado A, Gazzinelli R, Bortoluci K, Amarante-Mendes G, et al. Pathogen-induced proapoptotic phenotype and high CD95 (Fas) expression accompany a suboptimal CD8+ T-cell response: reversal by adenoviral vaccine. PLoS Pathog. 2012;8:e1002699. doi:10.1371/journal.ppat.1002699.
   PubMed Web of Science ®Google Scholar
• Dodi A, Ajayi I, Chang C, Beard M, Ashley S, Huang S, Thannickal V, Tschumperlin D, Sisson T, Horowitz J. Regulation of fibroblast Fas expression by soluble and mechanical pro-fibrotic stimuli. Respir Res. 2018;19:91. doi:10.1186/s12931-018-0801-4.
   PubMed Web of Science ®Google Scholar
• Yuksel M, Wang Y, Tai N, Peng J, Guo J, Beland K, Lapierre P, David C, Alvarez F, Colle I, et al. A novel “humanized mouse” model for autoimmune hepatitis and the association of gut microbiota with liver inflammation. Hepatology. 2015;62:1536–1550. doi:10.1002/hep.27998.
   PubMed Web of Science ®Google Scholar
• Ray K. Manipulating the gut microbiota to combat alcoholic hepatitis. Nat Rev Gastroenterol Hepatoly. 2019;17: 3–3. doi:10.1038/s41575-019-0246-3.
   Web of Science ®Google Scholar
• Loomba R, Seguritan V, Li W, Long T, Klitgord N, Bhatt A, Dulai P, Caussy C, Bettencourt R, Highlander S, et al. Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease. Cell Metab. 2017;25:1054–1062. doi:10.1016/j.cmet.2017.04.001.
   PubMed Web of Science ®Google Scholar
• Ren Y, Ye Z, Yang L, Jin L, Wei W, Deng Y, Chen X, Xiao C, Yu X, Xu H, et al. Fecal microbiota transplantation induces hepatitis B virus e-antigen (HBeAg) clearance in patients with positive HBeAg after long-term antiviral therapy. Hepatology. 2017;65:1765–1768. doi:10.1002/hep.29008.
   PubMed Web of Science ®Google Scholar
• Wei Y, Li Y, Yan L, Sun C, Miao Q, Wang Q, Xiao X, Lian M, Li B, Chen Y, et al. Alterations of gut microbiome in autoimmune hepatitis. Gut. 2020;69:569–577. doi:10.1136/gutjnl-2018-317836.
   PubMed Web of Science ®Google Scholar
• Ferrere G, Wrzosek L, Cailleux F, Turpin W, Puchois V, Spatz M, Ciocan D, Rainteau D, Humbert L, Hugot C, et al. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice. J Hepatol. 2017;66:806–815. doi:10.1016/j.jhep.2016.11.008.
   PubMed Web of Science ®Google Scholar
• Llopis M, Cassard A, Wrzosek L, Boschat L, Bruneau A, Ferrere G, Puchois V, Martin J, Lepage P, Le Roy T, et al. Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease. Gut. 2016;65:830–839. doi:10.1136/gutjnl-2015-310585.
   PubMed Web of Science ®Google Scholar
• Wu W, Lv L, Shi D, Ye J, Fang D, Guo F, Li Y, He X, Li L. Protective effect of Akkermansia muciniphila against immune-mediated liver injury in a mouse model. Front Microbiol. 2017;8:1804. doi:10.3389/fmicb.2017.01804.
   PubMed Web of Science ®Google Scholar
• Momose Y, Park S, Miyamoto Y, Itoh K. Design of species-specific oligonucleotide probes for the detection of Bacteroides and Parabacteroides by fluorescence in situ hybridization and their application to the analysis of mouse caecal Bacteroides-Parabacteroides microbiota. J Appl Microbiol. 2011;111:176–184. doi:10.1111/j.1365-2672.2011.05039.x.
   PubMed Web of Science ®Google Scholar
• Marques F, Nelson E, Chu P, Horlock D, Fiedler A, Ziemann M, Tan J, Kuruppu S, Rajapakse N, El-Osta A, et al. High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice. Circulation. 2017;135:964–977. doi:10.1161/CIRCULATIONAHA.116.024545.
   PubMed Web of Science ®Google Scholar
• Then C, Paillas S, Wang X, Hampson A, Kiltie A. Association of Bacteroides acidifaciens relative abundance with high-fibre diet-associated radiosensitisation. BMC Biol. 2020;18:102. doi:10.1186/s12915-020-00836-x.
   PubMedGoogle Scholar
• Yang J, Lee Y, Kim Y, Lee S, Ryu S, Fukuda S, Hase K, Yang C, Lim H, Kim M, et al. Gut commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in mice. Mucosal Immunol. 2017;10:104–116. doi:10.1038/mi.2016.42.
   PubMed Web of Science ®Google Scholar
• Wu L, Yan Q, Chen F, Cao C, Wang S. Bupleuri radix extract ameliorates impaired lipid metabolism in high-fat diet-induced obese mice via gut microbia-mediated regulation of FGF21 signaling pathway. Biomed Pharmacother. 2021;135:111187. doi:10.1016/j.biopha.2020.111187.
   PubMed Web of Science ®Google Scholar
• Aoki R, Onuki M, Hattori K, Ito M, Yamada T, Kamikado K, Kim Y, Nakamoto N, Kimura I, Clarke J, et al. Commensal microbe-derived acetate suppresses NAFLD/NASH development via hepatic FFAR2 signalling in mice. Microbiome. 2021;9:188. doi:10.1186/s40168-021-01125-7.
   PubMed Web of Science ®Google Scholar
• Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M, Agdashian D, Terabe M, Berzofsky J, Fako V, et al. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science. 2018;360:eaan5931. doi:10.1126/science.aan5931.
   PubMed Web of Science ®Google Scholar
• Smirnova E, Puri P, Muthiah M, Daitya K, Brown R, Chalasani N, Liangpunsakul S, Shah V, Gelow K, Siddiqui M, et al. Fecal microbiome distinguishes alcohol consumption from alcoholic hepatitis but does not discriminate disease severity. Hepatology. 2020;72:271–286. doi:10.1002/hep.31178.
   PubMed Web of Science ®Google Scholar
• Engevik M, Herrmann B, Ruan W, Engevik A, Engevik K, Ihekweazu F, Shi Z, Luck B, Chang-Graham A, Esparza M, et al. Bifidobacterium dentium-derived y-glutamylcysteine suppresses ER-mediated goblet cell stress and reduces TNBS-driven colonic inflammation. Gut Microbes. 2021;13:1–21. doi:10.1080/19490976.2021.1902717.
   PubMed Web of Science ®Google Scholar
• Cazanave S, Berson A, Haouzi D, Vadrot N, Fau D, Grodet A, Lettéron P, Feldmann G, El-Benna J, Fromenty B, et al. High hepatic glutathione stores alleviate Fas-induced apoptosis in mice. J Hepatol. 2007;46:858–868. doi:10.1016/j.jhep.2006.11.015.
   PubMed Web of Science ®Google Scholar
• Thomsen M, Bakiri L, Hasenfuss S, Hamacher R, Martinez L, Wagner E. JUNB/AP-1 controls IFN-γ during inflammatory liver disease. J Clin Invest. 2013;123:5258–5268. doi:10.1172/JCI70405.
   PubMed Web of Science ®Google Scholar
• Zhang S, Liang R, Luo W, Liu C, Wu X, Gao Y, Hao J, Cao G, Chen X, Wei J, et al. High susceptibility to liver injury in IL-27 p28 conditional knockout mice involves intrinsic interferon-γ dysregulation of CD4+ T cells. Hepatology. 2013;57:1620–1631. doi:10.1002/hep.26166.
   PubMed Web of Science ®Google Scholar
• Mollinedo F, Gajate C. Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy. Drug Resist Updat. 2006;9:51–73. doi:10.1016/j.drup.2006.04.002.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhao Y, Park YK, Lee JY, Gao L, Zhao J, Wang L. Loss of PDK4 switches the hepatic NF-κB/TNF pathway from pro-survival to pro-apoptosis. Hepatology. 2018;68:1111–1124. doi:10.1002/hep.29902.
   PubMed Web of Science ®Google Scholar
• Lian F, Wang Y, Xiao Y, Wu X, Xu H, Liang L, Yang X. Activated farnesoid X receptor attenuates apoptosis and liver injury in autoimmune hepatitis. Mol Med Report. 2015;12:5821–5827. doi:10.3892/mmr.2015.4159.
   PubMed Web of Science ®Google Scholar
• Zhuang P, Li H, Jia W, Shou Q, Zhu Y, Mao L, Wang W, Wu F, Chen X, Wan X, et al. Eicosapentaenoic and docosahexaenoic acids attenuate hyperglycemia through the microbiome-gut-organs axis in db/db mice. Microbiome. 2021;9:185. doi:10.1186/s40168-021-01126-6.
   PubMed Web of Science ®Google Scholar
• Behary J, Amorim N, Jiang X, Raposo A, Gong L, McGovern E, Ibrahim R, Chu F, Stephens C, Jebeili H, et al. Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma. Nat Commun. 2021;12:187. doi:10.1038/s41467-020-20422-7.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhao D, Qian M, Liu J, Pan C, Zhang X, Duan X, Zhang Y, Jia W, Wang L. Amlodipine, an anti-hypertensive drug, alleviates non-alcoholic fatty liver disease by modulating gut microbiota. Br J Pharmacol. 2021. doi:10.1111/bph.15768.
   Web of Science ®Google Scholar
• Lou J, Jiang Y, Rao B, Li A, Ding S, Yan H, Zhou H, Liu Z, Shi Q, Cui G, et al. Fecal microbiomes distinguish patients with autoimmune hepatitis from healthy individuals. Front Cell Infect Microbiol. 2020;10:342. doi:10.3389/fcimb.2020.00342. eCollection 2020.
   PubMed Web of Science ®Google Scholar
• Elsherbiny N, Rammadan M, Hassan E, Ali M, El-Rehim A, Abbas W, Abozaid M, Hassanin E, Hetta H. Autoimmune hepatitis: shifts in gut microbiota and metabolic pathways among egyptian patients. Microorganisms. 2020;8:1011. doi:10.3390/microorganisms8071011.
   PubMed Web of Science ®Google Scholar
• Kim S, Eun J, Cho H, Song D, Kim C, Kim Y, Lee S, Kim Y, Yang J, Choi J, et al. Microbiome as a potential diagnostic and predictive biomarker in severe alcoholic hepatitis. Aliment Pharmacol Ther. 2021;53:540–551. doi:10.1111/apt.16200.
   PubMed Web of Science ®Google Scholar
• Saeedi B, Liu K, Owens J, Hunter-Chang S, Camacho M, Eboka R, Chandrasekharan B, Baker N, Darby T, Robinson B, et al. Gut-resident Lactobacilli activate hepatic Nrf2 and protect against oxidative liver injury. Cell Metab. 2020;31:956–968. doi:10.1016/j.cmet.2020.03.006.
   PubMed Web of Science ®Google Scholar
• Grander C, Grabherr F, Spadoni I, Enrich B, Oberhuber G, Rescigno M, Tilg H. The role of gut vascular barrier in experimental alcoholic liver disease and A. muciniphila supplementation. Gut Microbes. 2020;12:1851986. doi:10.1080/19490976.2020.1851986.
   PubMed Web of Science ®Google Scholar
• Qian M, Hu H, Yao Y, Zhao D, Wang S, Pan C, Duan X, Gao Y, Liu J, Zhang Y, et al. Coordinated changes of gut microbiome and lipidome differentiates nonalcoholic steatohepatitis (NASH) from isolated steatosis. Liver Int. 2020;40:622–637. doi:10.1111/liv.14316.
   PubMed Web of Science ®Google Scholar
• Zha H, Fang D, van der Reis A, Chang K, Yang L, Xie J, Shi D, Xu Q, Li Y, Li L. Vital members in the gut microbiotas altered by two probiotic Bifidobacterium strains against liver damage in rats. BMC Microbiol. 2020;20:144. doi:10.1186/s12866-020-01827-2.
   PubMed Web of Science ®Google Scholar
• Wrzosek L, Ciocan D, Hugot C, Spatz M, Dupeux M, Houron C, Lievin-Le Moal V, Puchois V, Ferrere G, Trainel N, et al. Microbiota tryptophan metabolism induces aryl hydrocarbon receptor activation and improves alcohol-induced liver injury. Gut. 2021;70:1299–1308. doi:10.1136/gutjnl-2020-321565.
   PubMed Web of Science ®Google Scholar
• Li H, Wu G, Zhao L, Zhang M. Suppressed inflammation in obese children induced by a high-fiber diet is associated with the attenuation of gut microbial virulence factor genes. Virulence. 2021;12:1754–1770. doi:10.1080/21505594.2021.1948252.
   PubMed Web of Science ®Google Scholar
• Beyaz S, Chung C, Mou H, Bauer-Rowe K, Xifaras M, Ergin I, Dohnalova L, Biton M, Shekhar K, Eskiocak O, et al. Dietary suppression of MHC class II expression in intestinal epithelial cells enhances intestinal tumorigenesis. Cell Stem Cell. 2021;28:1922–1935.e5. doi:10.1016/j.stem.2021.08.007.
   PubMed Web of Science ®Google Scholar
• Gao R, Wang C, Han A, Tian Y, Ren S, Lv W, Chen A, Zhang J. Emodin improves intestinal health and immunity through modulation of gut microbiota in mice infected by pathogenic Escherichia coli O. Animals. 2021;11:3314. doi:10.3390/ani11113314.
   Web of Science ®Google Scholar
• Lan H, Hong W, Qian D, Peng F, Li H, Liang C, Du M, Gu J, Mai J, Bai B, et al. Quercetin modulates the gut microbiota as well as the metabolome in a rat model of osteoarthritis. Bioengineered. 2021;12:6240–6250. doi:10.1080/21655979.2021.1969194.
   PubMed Web of Science ®Google Scholar
• Lin H, Wang Q, Yuan M, Liu L, Chen Z, Zhao Y, Das R, Duan Y, Xu X, Xue Y, et al. The prolonged disruption of a single-course amoxicillin on mice gut microbiota and resistome, and recovery by inulin, Bifidobacterium longum and fecal microbiota transplantation. Environ Pollut. 2020;265:114651. doi:10.1016/j.envpol.2020.114651.
   PubMed Web of Science ®Google Scholar
• Zheng H, Xu P, Jiang Q, Xu Q, Zheng Y, Yan J, Ji H, Ning J, Zhang X, Li C, et al. Depletion of acetate-producing bacteria from the gut microbiota facilitates cognitive impairment through the gut-brain neural mechanism in diabetic mice. Microbiome. 2021;9:145. doi:10.1186/s40168-021-01088-9.
   PubMed Web of Science ®Google Scholar
• Ray P, Pandey U, Das D, Aich P. Vancomycin-induced changes in host immunity and behavior: comparative genomic and metagenomic analysis in C57BL/6 and BALB/c mice. Dig Dis Sci. 2021;66:3776–3791. doi:10.1007/s10620-020-06729-x.
   PubMed Web of Science ®Google Scholar
• Moshkelgosha S, Verhasselt H, Masetti G, Covelli D, Biscarini F, Horstmann M, Daser A, Westendorf A, Jesenek C, Philipp S, et al. Modulating gut microbiota in a mouse model of Graves’ orbitopathy and its impact on induced disease. Microbiome. 2021;9:45. doi:10.1186/s40168-020-00952-4.
   PubMed Web of Science ®Google Scholar
• Zhang H, Li Z, Wang L, Tian G, Tian J, Yang Z, Cao G, Zhou H, Zhao L, Wu Z, et al. Critical role of myeloid-derived suppressor cells in tumor-induced liver immune suppression through inhibition of NKT cell function. Front Immunol. 2017;8:129. doi:10.3389/fimmu.2017.00129. eCollection 2017.
   PubMed Web of Science ®Google Scholar
• O’Connell J, Bennett M, Nally K, Houston A, O’Sullivan G, Shanahan F. Altered mechanisms of apoptosis in colon cancer: fas resistance and counterattack in the tumor-immune conflict. Ann N Y Acad Sci. 2000;910:178–192. doi:10.1111/j.1749-6632.2000.tb06708.x. discussion 193–175.
   PubMed Web of Science ®Google Scholar
• Schulze-Bergkamen H, Brenner D, Krueger A, Suess D, Fas S, Frey C, Dax A, Zink D, Büchler P, Müller M, et al. Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt. Hepatology. 2004;39:645–654. doi:10.1002/hep.20138.
   PubMed Web of Science ®Google Scholar
• Ji Y, Yin Y, Li Z, Zhang W. Gut microbiota-derived components and metabolites in the progression of non-alcoholic fatty liver disease (NAFLD). Nutrients. 2019;11:1712. doi:10.3390/nu11081712.
   PubMed Web of Science ®Google Scholar
• Yamaguchi A, Teratani T, Chu P, Suzuki T, Taniki N, Mikami Y, Shiba S, Morikawa R, Amiya T, Aoki R, et al. Hepatic adenosine triphosphate reduction through the short-chain fatty acids-peroxisome proliferator-activated receptor γ-uncoupling protein 2 axis alleviates immune-mediated acute hepatitis in inulin-supplemented mice. Hepatol Commun. 2021;5:1555–1570. doi:10.1002/hep4.1742.
   PubMed Web of Science ®Google Scholar
• Jiang L, Schnabl B. Gut microbiota in liver disease: what do we know and what do we not know? Physiology. 2020;35:261–274. doi:10.1152/physiol.00005.2020.
   PubMed Web of Science ®Google Scholar
• Suk K, Kim D. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol. 2019;13:193–204. doi:10.1080/17474124.2019.1569513.
   PubMed Web of Science ®Google Scholar
• Orabi D, Osborn L, Fung K, Massey W, Horak A, Aucejo F, Choucair I, DeLucia B, Wang Z, Claesen J, et al. A surgical method for continuous intraportal infusion of gut microbial metabolites in mice. JCI Insight. 2021;6:e145607. doi:10.1172/jci.insight.145607.
   PubMed Web of Science ®Google Scholar
• Wu S, Sa R, Gu Z, Zhao P, Yu J, Wang Y, Ge B. The protective effect of aesculus hippocastanum (Venoplant®) against Concanavalin A-induced liver injury. Pharmacology. 2019;104:196–206. doi:10.1159/000501258.
   PubMed Web of Science ®Google Scholar
• Feng T, Wang J. Oxidative stress tolerance and antioxidant capacity of lactic acid bacteria as probiotic: a systematic review. Gut Microbes. 2020;12:1801944. doi:10.1080/19490976.2020.1801944.
   PubMed Web of Science ®Google Scholar
• Janowiak B, Griffith O. Glutathione synthesis in Streptococcus agalactiae. One protein accounts for gamma-glutamylcysteine synthetase and glutathione synthetase activities. J Biol Chem. 2005;280:11829–11839. doi:10.1074/jbc.M414326200.
   PubMed Web of Science ®Google Scholar
• Kullisaar T, Zilmer M, Mikelsaar M, Vihalemm T, Annuk H, Kairane C, Kilk A. Two antioxidative lactobacilli strains as promising probiotics. Int J Food Microbiol. 2002;72:215–224. doi:10.1016/s0168-1605(01)00674-2.
   PubMed Web of Science ®Google Scholar
• Wang K, Liao M, Zhou N, Bao L, Ma K, Zheng Z, Wang Y, Liu C, Wang W, Wang J, et al. Parabacteroides distasonis alleviates obesity and metabolic dysfunctions via production of succinate and secondary bile acids. Cell Rep. 2019;26:222–235.e5. doi:10.1016/j.celrep.2018.12.028.
   PubMed Web of Science ®Google Scholar
• Revelle W. Procedures for psychological, psychometric, and personalityresearch [R package psych version 1.8.4].
   Google Scholar